European Medicines Agency (EMA)
Featured news and updated for European Academics and researchers in the field of medicine development. The European Medicines Agency is a decentralised agency of the European Union responsible for the evaluation, supervision and safety monitoring of medicines.
News - European Medicines Agency (EMA)
EMA recommends measures to minimise serious outcomes of known side effect with painkiller metamizole. Product information to be updated to raise awareness of known risk of agranulocytosis and facilitate its early detection and diagnosis. 6 September 2024.
What's new - European Medicines Agency (EMA)
Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. This overview covers up to two months back. What's new - Menu tabs. Current month Previous month Two months ago.
News and events | European Medicines Agency (EMA)
EMA's newsletters provide updates on various topics to patients, healthcare professionals, animal healthcare professionals and users of veterinary medicines, and the pharmaceutical industry. Check EMA's annual reports for insights into our regulatory procedures, activities, and …
Coronavirus disease (COVID-19) - European Medicines Agency …
The European Medicines Agency (EMA) contributes to global efforts to protect people from COVID-19. EMA enables the development and approval of safe and effective treatments and vaccines and provides reliable information to patients and healthcare professionals in the European Union (EU).
COVID-19 medicines | European Medicines Agency (EMA)
Oct 14, 2024 · COVID-19 vaccines: strains, use and age ranges. Safety information for authorised COVID-19 vaccines. Ongoing clinical trials. Updated on 14 October 2024: 'Authorised COVID-19 vaccines' and 'COVID-19 vaccines: strains, use and age ranges' sections.
Committee for Medicinal Products for Human Use (CHMP)
The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible for human medicines. It plays a vital role in the authorisation of medicines in the European Union. The committee meets once a month. EMA publishes agendas, minutes and highlights of its plenary meetings.
Medicines | European Medicines Agency (EMA)
The European Medicines Agency (EMA) facilitates development and access to medicines for countries within the European Union (EU). EMA evaluates applications for marketing authorisation submitted via the centralised procedure, monitors the safety of medicines across their lifecycle and provides information to healthcare professionals and ...
EMA statement on ongoing review of GLP-1 receptor agonists
Jul 11, 2023 · EMA’s safety committee, the PRAC, is reviewing data on the risk of suicidal thoughts and thoughts of self-harm with medicines known as GLP-1 receptor agonists, 1 including Ozempic (semaglutide), Saxenda (liraglutide) and Wegovy (semaglutide). These medicines are used for weight loss and for treating type 2 diabetes.
Medical devices - European Medicines Agency (EMA)
The Medical Devices Regulation foresees that the European Commission may consult EMA on products that borderline with medicines. EMA's Innovation Task Force provides advice to medicine developers on eligibility to EMA procedures relating to the research and development of borderline products.